{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:46:58Z","timestamp":1790567218085,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":5457,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1111\/j.1538-7836.2007.02796.x","type":"journal-article","created":{"date-parts":[[2007,10,12]],"date-time":"2007-10-12T05:18:58Z","timestamp":1192166338000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis"],"prefix":"10.1016","volume":"6","author":[{"given":"W.J.","family":"WIERSINGA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.M.","family":"MEIJERS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"LEVI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"VAN \u2018T VEER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.P.","family":"DAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"PEACOCK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"VAN DER POLL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro1385","article-title":"Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei","volume":"4","author":"Wiersinga","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: epidemiology, pathophysiology, and management","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","article-title":"Septic shock","volume":"365","author":"Annane","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0025","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0030","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1473-3099(01)00093-7","article-title":"Immunotherapy of sepsis","volume":"1","author":"Van Der Poll","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0045","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0055","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High\u2010dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0065","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/IAI.01733-06","article-title":"High\u2010Throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei","volume":"75","author":"Wiersinga","year":"2007","journal-title":"Infect Immun"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0070","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4049\/jimmunol.177.2.1189","article-title":"Endogenous tissue\u2010type plasminogen activator is protective during Escherichia coli\u2010induced abdominal sepsis in mice","volume":"177","author":"Renckens","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/mcpr.2001.0392","article-title":"Quantitative analysis of beta\u2010actin, beta\u20102\u2010microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT\u2010PCR","volume":"16","author":"Lupberger","year":"2002","journal-title":"Mol Cell Probes"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0049-3848(87)90454-3","article-title":"A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions","volume":"47","author":"Sandset","year":"1987","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0085","first-page":"179","article-title":"Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin\u2010antithrombin\u2010III complex\/plasmin\u2010alpha\u20102\u2010antiplasmin complex ratio","volume":"22","author":"Kario","year":"1992","journal-title":"Haemostasis"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0090","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1084\/jem.185.6.1143","article-title":"Epinephrine exerts anticoagulant effects during human endotoxemia","volume":"185","author":"Van Der Poll","year":"1997","journal-title":"J Exp Med"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0038-1657303","article-title":"Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis","volume":"49","author":"Osterud","year":"1983","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0100","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.V95.4.1124.002k20_1124_1129","article-title":"Tissue factor pathway inhibitor dose\u2010dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia","volume":"95","author":"De Jonge","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0105","first-page":"127","article-title":"Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody","volume":"33","author":"Taylor","year":"1991","journal-title":"Circ Shock"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1172\/JCI116934","article-title":"Inhibition of endotoxin\u2010induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti\u2010tissue factor antibody in chimpanzees","volume":"93","author":"Levi","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1538-7836.2004.00548.x","article-title":"Tissue factor in neutrophils: yes","volume":"2","author":"Nakamura","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1538-7836.2004.00546.x","article-title":"Tissue factor in neutrophils: no","volume":"2","author":"Osterud","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0125","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1182\/blood-2003-03-0713","article-title":"Induction of microparticle\u2010 and cell\u2010associated intravascular tissue factor in human endotoxemia","volume":"103","author":"Aras","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2006.09.001","article-title":"Circulating microparticles: pathophysiology and clinical implications","volume":"21","author":"Piccin","year":"2007","journal-title":"Blood Rev"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.mbc.0000172329.66130.d2","article-title":"Generation of tissue factor\u2010rich microparticles in an ex vivo whole blood model","volume":"16","author":"Breimo","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0140","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1097\/01.CCM.0000186414.86162.03","article-title":"Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis","volume":"33","author":"Soriano","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0145","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/00003246-200208000-00009","article-title":"Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis","volume":"30","author":"Gando","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-0037-1616084","article-title":"Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients","volume":"86","author":"Raaphorst","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0155","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/s-0038-1650392","article-title":"Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis","volume":"75","author":"Mesters","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0160","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/cc2459","article-title":"Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro\u2010organism [ISRCTN74215569]","volume":"8","author":"Kinasewitz","year":"2004","journal-title":"Crit Care"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.CCM.0000153520.31562.48","article-title":"Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure","volume":"33","author":"Dhainaut","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0170","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1538-7836.2004.00955.x","article-title":"Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation","volume":"2","author":"Dhainaut","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2005.06.001","article-title":"Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram\u2010negative sepsis caused by Burkholderia pseudomallei","volume":"10","author":"LaRosa","year":"2006","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0180","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tcm.2005.07.004","article-title":"Two\u2010way interactions between inflammation and coagulation","volume":"15","author":"Levi","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0185","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM199006073222302","article-title":"Activation of coagulation after administration of tumor necrosis factor to normal subjects","volume":"322","author":"Van Der Poll","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0190","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood.V86.3.1027.1027","volume":"86","author":"Jansen","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0195","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1055\/s-0038-1650653","article-title":"Interleukin\u20106 stimulates coagulation, not fibrinolysis, in humans","volume":"76","author":"Stouthard","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0200","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1086\/314636","article-title":"Interleukin\u201012 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees","volume":"179","author":"Lauw","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1538-7836.2007.02796.x_bb0205","first-page":"637","article-title":"Acute systemic melioidosis: an autopsy study of six cases","volume":"19","author":"Atisook","year":"1988","journal-title":"Southeast Asian J Trop Med Public Health"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02796.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622131752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622131752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02796.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:45:28Z","timestamp":1761533128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622131752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1538783622131752"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02796.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02796.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}